Request Demo
Last update 08 Dec 2025
AZD0516
Last update 08 Dec 2025
Overview
Basic Info
Drug Type Antibody drug conjugate (ADC) |
Synonyms- |
Target |
Action inhibitors |
Mechanism STEAP2 inhibitors(STEAP2 metalloreductase inhibitors), TOP1 inhibitors(DNA topoisomerase I inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Login to view timeline
Structure/Sequence
Boost your research with our ADC technology data.
login
or
Related
1
Clinical Trials associated with AZD0516NCT07181161
A Modular Phase I/IIa, Open-label, Multi-centre Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of AZD0516 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Metastatic Prostate Cancer
100 Clinical Results associated with AZD0516
Login to view more data
100 Translational Medicine associated with AZD0516
Login to view more data
100 Patents (Medical) associated with AZD0516
Login to view more data
100 Deals associated with AZD0516
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Metastatic Prostate Carcinoma | Phase 2 | United States | 01 Oct 2025 | |
| Metastatic Prostate Carcinoma | Phase 2 | China | 01 Oct 2025 | |
| Metastatic Prostate Carcinoma | Phase 2 | Japan | 01 Oct 2025 | |
| Metastatic Prostate Carcinoma | Phase 2 | Brazil | 01 Oct 2025 | |
| Metastatic Prostate Carcinoma | Phase 2 | France | 01 Oct 2025 | |
| Metastatic Prostate Carcinoma | Phase 2 | Italy | 01 Oct 2025 | |
| Metastatic Prostate Carcinoma | Phase 2 | Poland | 01 Oct 2025 | |
| Metastatic Prostate Carcinoma | Phase 2 | South Korea | 01 Oct 2025 | |
| Metastatic Prostate Carcinoma | Phase 2 | Spain | 01 Oct 2025 | |
| Metastatic Prostate Carcinoma | Phase 2 | United Kingdom | 01 Oct 2025 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free